We are live on
!
Find out more
DCP
Distillate Capital Partners Portfolio holdings
AUM
$1.9B
1-Year Est. Return
2.22%
This Fund
S&P 500
This Quarter
Est. Return
+16.38%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
–
AUM
$1.08M
AUM Growth
-$746M
(-100%)
Cap. Flow
-$766M
Cap. Flow
% of AUM
-70,775.35%
Top 10 Holdings %
Top 10 Hldgs %
12.7%
Holding
175
New
70
Increased
–
Reduced
30
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$13.3K |
| 2 |
Moderna
MRNA
|
+$13.2K |
| 3 |
Steel Dynamics
STLD
|
+$12.7K |
| 4 |
Gilead Sciences
GILD
|
+$12.6K |
| 5 |
Phillips 66
PSX
|
+$12K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$27.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$16.7M |
| 3 |
Apple
AAPL
|
+$16.6M |
| 4 |
AbbVie
ABBV
|
+$16.3M |
| 5 |
UnitedHealth
UNH
|
+$15.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 21.4% |
| 2 | Technology | 19.42% |
| 3 | Healthcare | 18.84% |
| 4 | Materials | 9.09% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $17.4K | 1.61% |
153
-76,750
| -100% | -$6.37M |
|
|
2
Halliburton
HAL
$26.6B
| $14.8K | 1.37% |
+376
| New | +$13.3K |
|
|
3
Moderna
MRNA
$22.3B
| $14.5K | 1.34% |
+81
| New | +$13.2K |
|
|
4
Gilead Sciences
GILD
$161B
| $13.7K | 1.26% |
+159
| New | +$12.6K |
|
|
5
Steel Dynamics
STLD
$36.7B
| $12.9K | 1.19% |
+132
| New | +$12.7K |
|
6
Apollo Global Management
APO
$74.3B
| $12.8K | 1.18% |
+201
| New | +$11.9K |
|
7
Freeport-McMoran
FCX
$90.9B
| $12.8K | 1.18% |
+337
| New | +$11.8K |
|
8
United Rentals
URI
$69.3B
| $12.8K | 1.18% |
36
-25,825
| -100% | -$8.49M |
|
9
United Therapeutics
UTHR
$25.7B
| $12.8K | 1.18% |
+46
| New | +$11.6K |
|
10
Omnicom Group
OMC
$21.8B
| $12.7K | 1.18% |
156
-97,020
| -100% | -$7.2M |
|
11
Viatris
VTRS
$20.4B
| $12.7K | 1.17% |
+1,140
| New | +$11.9K |
|
12
inTEST
INTT
$170M
| $12.6K | 1.17% |
+379
| New | +$3.52K |
|
13
D.R. Horton
DHI
$40.7B
| $12.6K | 1.16% |
+141
| New | +$11.3K |
|
14
Merck
MRK
$315B
| $12.5K | 1.16% |
+113
| New | +$11.6K |
|
15
APA Corp
APA
$13.1B
| $12.4K | 1.15% |
+266
| New | +$11.9K |
|
16
Best Buy
BBY
$17.7B
| $12.4K | 1.14% |
+154
| New | +$11.3K |
|
|
17
Phillips 66
PSX
$83.6B
| $12.2K | 1.13% |
+117
| New | +$12K |
|
18
ExxonMobil
XOM
$643B
| $12K | 1.11% |
+109
| New | +$11.7K |
|
19
Chevron
CVX
$386B
| $11.8K | 1.09% |
+66
| New | +$11.5K |
|
20
Cencora
COR
$60.5B
| $11.8K | 1.09% |
+71
| New | +$11.2K |
|
21
Broadcom
AVGO
$1.85T
| $11.7K | 1.09% |
210
-253,380
| -100% | -$12.7M |
|
22
KLA
KLAC
$235B
| $11.7K | 1.08% |
+310
| New | +$10.8K |
|
23
Cummins
CMI
$89.5B
| $11.6K | 1.07% |
48
-33,642
| -100% | -$8M |
|
24
Cigna
CI
$74.7B
| $11.6K | 1.07% |
35
-36,664
| -100% | -$11.6M |
|
25
Lennar Class A
LEN
$20.4B
| $11.6K | 1.07% |
+132
| New | +$10.7K |
|
Similar funds
EP
FTCM
OPCM
IAN
BOH
VC
MC
TF
Distillate Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Distillate Capital Partners held 175 positions worth $1.08M, down 100% from $747M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Distillate Capital Partners withdrew a net $766M in Q4 2022, closing 75 positions and reducing 30 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $27.7M position sold in full.
By sector, the portfolio is most concentrated in Energy at 21% of assets, up from 2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Distillate Capital Partners opened a new position in Halliburton worth $14.8K.
- Distillate Capital Partners's largest Q4 2022 buy was Halliburton: 376 shares worth $14.8K.
- Distillate Capital Partners's biggest Q4 2022 reduction was AbbVie, cutting an estimated $16.3M.
- Distillate Capital Partners fully exited Alphabet (Google) Class A in Q4 2022, selling an estimated $27.7M.
- Distillate Capital Partners's ten largest holdings make up 13% of its $1.08M portfolio in Q4 2022.
- Distillate Capital Partners opened 70 new positions and closed 75 in Q4 2022.
- Distillate Capital Partners's portfolio value fell 100% quarter-over-quarter to $1.08M.
Based on Distillate Capital Partners's 13F filing for Q4 2022, filed 15 Feb 2023.